- Home
- ITIC vs VSTM Comparison
ITIC vs VSTM Comparison
Compare ITIC & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ITIC | VSTM |
|---|---|---|
| Founded | 1972 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 517.1M | 470.7M |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | ITIC | VSTM |
|---|---|---|
| Price | $271.94 | $6.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $13.38 |
| AVG Volume (30 Days) | 18.2K | ★ 2.0M |
| Earning Date | 02-13-2026 | 03-19-2026 |
| Dividend Yield | ★ 3.98% | N/A |
| EPS Growth | ★ 25.81 | N/A |
| EPS | ★ 19.00 | N/A |
| Revenue | ★ $273,864,000.00 | $13,379,000.00 |
| Revenue This Year | N/A | $208.54 |
| Revenue Next Year | N/A | $251.40 |
| P/E Ratio | $13.95 | ★ N/A |
| Revenue Growth | 13.63 | ★ 33.79 |
| 52 Week Low | $190.20 | $4.01 |
| 52 Week High | $288.98 | $11.25 |
Technical Indicators
Market Signals| Indicator | ITIC | VSTM |
|---|---|---|
| Relative Strength Index (RSI) | 66.71 | 38.41 |
| Support Level | $249.28 | $6.01 |
| Resistance Level | $259.00 | $6.53 |
| Average True Range (ATR) | 7.34 | 0.40 |
| MACD | 2.01 | 0.03 |
| Stochastic Oscillator | 99.73 | 19.60 |
Price Performance
Historical ComparisonAbout ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.